Since 2015, GPX Medical has coordinated a three-year research project funded through the European Eurostars Program – Neo-Lung. Collaborative partners in the project have been Lund University in Sweden, the Norwegian company Norsk Elektro Optikk, and the German laser company Nanoplus. The project is officially closed on 31 December 2018, but on 19-20 November, a final meeting of the project was held in Lund. At the same time, a clinical study is concluded as part of the project at Skåne University Hospital in Lund. The project has been a great success and there are now plans for further cooperation.

About GPX Medical

GPX Medical AB (publ) is revolutionizing neonatal intensive care with NEOLA®, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a cutting-edge technology that measures lung volume changes and oxygen gas concentration. NEOLA® has the potential to provide better care, fewer days in intensive care and healthier lives for preterm born infants. Founded in 2016 and headquartered in Lund, Sweden, GPX Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:


GPX Medical AB (publ)
Ideon Science Park
Scheelevägen 27
223 63 Lund

Organization number: 559069-9012